EMPrint Ablate and RESect System

· Medtronic

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EMPrint Ablate and RESect System, covering 2018-04-05 to 2018-04-05. Get the full timeline:

Most recent: Clinical Trial Update: The EMPrint™ Ablate and RESect Study in Patients With Metastatic Lung Tumors (EMPRESS) [NA]